Thu, February 5, 2009
Wed, February 4, 2009
Tue, February 3, 2009
Mon, February 2, 2009
Sun, February 1, 2009
Sat, January 31, 2009
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
Thu, January 29, 2009
Wed, January 28, 2009
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ] - Market Wire
SCOR: SCOR sets up Zurich Hub
Mon, January 26, 2009
Sun, January 25, 2009
Fri, January 23, 2009
Thu, January 22, 2009

Daxor Corp.: Daxor Announces Tahlequah City Hospital of Tahlequah, OK Acquires BVA-100 Blood Volume Analyzer


//health-fitness.news-articles.net/content/2009/ .. h-ok-acquires-bva-100-blood-volume-analyzer.html
Published in Health and Fitness on Friday, January 30th 2009 at 7:54 GMT, Last Modified on 2009-01-30 07:55:07 by Market Wire   Print publication without navigation


NEW YORK, NY--(Marketwire - January 30, 2009) - Daxor Corporation (AMEX: [ DXR ]), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Tahlequah City Hospital of Tahlequah, Oklahoma.

Tahlequah City Hospital (TCH) is a 100-bed rural hospital with a strategic plan designed to turn TCH into a regional healthcare center. By recruiting top physicians in their respective field and acquiring state-of-the-art technology, TCH has already implemented a cardiovascular open-heart surgery program and a comprehensive nephrology program including dialysis services.

Dr. James Madison, TCH's Director of Nephrology, noted that, "Tahlequah's patient population is over-represented in the area of kidney disease. With the high incidence of diabetes and hypertension we are using sophisticated techniques to support the needs of our open-heart and nephrology patients. I've seen the benefit of treating patients based upon an intravascular blood volume measurement, which is why the inclusion of this service is an important adjunct to our program and demonstrates TCH's commitment to providing the best of care."

Dr. Joseph Feldschuh, Daxor's C.E.O. and a practicing cardiologist, stated that, "The use of the BVA-100 by Tahlequah City Hospital is a critical step forward to improving the care of renal dialysis patients, who undergo major changes in blood volume during their course of dialysis. It is expected that utilization of the BVA-100 will enable physicians to provide a more precise dialysis treatment."

Daxor's Blood Volume Analyzer BVA-100 will be located within TCH's Nuclear Medicine Department and will be utilized to diagnose a variety of patient blood volume derangements.

Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website [ www.Daxor.com ].


Publication Contributing Sources

Similar Health and Fitness Publications